Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

DUSSELDORF, Germany, February 26 /PRNewswire/ --

- Sales in 2007 Increased by 48.1% to EUR957.7m

- Operating Results (Adjusted EBITDA) up by 48.1% at EUR181.6m

- Proposed Dividend: EUR0.40 Per Share

- CEO Dr. Axel Herberg: "For the Financial Year 2008 we Expect Further Sales Growth, With an Improved Margin."

FOSTER CITY, California, February 26 /PRNewswire/ --

- Appoints Industry Veteran Eduard Blonk to Head European Operations

Asoka USA, a leading HomePlug(R) powerline network solutions provider, announced today the opening of its European headquarters in Amsterdam, Netherlands. Running the office will be Asoka's Vice President of Europe, Middle East and Africa (EMEA) Sales and Marketing, Eduard Blonk. Blonk, most recently Senior Vice President global sales key accounts for Siemens, brings extensive telecom industry experience and a strong familiarity of the EMEA marketplace.

DUSSELDORF, Germany, February 26 /PRNewswire/ -- Mr. Gerhard Schulze is appointed Chairman of the Supervisory Board of Gerresheimer AG with effect from February 25, 2008.

Mr. Lionel Assant, partner of Blackstone Group International Ltd., London, has resigned from the office of Chairman but continues to be a member of the Supervisory Board.

Gerresheimer is a pharmaceutical & life science supply and services company with market leading positions of specialty products made of glass and plastic. Gerresheimer owns 41 production sites in Europe, America and Asia and employs approximately 10,800 employees worldwide.

LAUSANNE, Switzerland and NEWTOWN, Pennsylvania, February 26 /PRNewswire/ --

- Products and Pipeline to Enhance Galderma's Position in Dermatology

Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, and CollaGenex Pharmaceuticals, Inc. (Nasdaq: CGPI) today announced a definitive agreement pursuant to which Galderma's U.S. holding company, Galderma Laboratories, Inc., will acquire all of the outstanding shares of CollaGenex at a price of US$16.60 per share in cash, representing approximately US$420 million for the equity of CollaGenex. The transaction was unanimously approved by the boards of directors of Galderma and CollaGenex.

PARSIPPANY, New Jersey, February 25 /PRNewswire/ --

Tanager AudioWorks, Inc. today announced the availability of their Chirp(TM) Virtual MIDI Keyboard Controller software. Chirp turns a user's computer keyboard into a MIDI keyboard controller, allowing a user to write or compose music without the need for a physical keyboard controller. Chirp takes advantage of the new Adobe AIR(TM) rich internet application (RIA) development environment.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080225/NYM127LOGO )

PARSIPPANY, New Jersey, February 25 /PRNewswire/ --